2 Amendments of Anja HAZEKAMP related to 2020/2162(DEC)
Amendment 5 #
Draft opinion
Paragraph 4 a (new)
Paragraph 4 a (new)
4 a. Notes with satisfaction that EFSA is actively moving towards cutting edge technologies, incorporating new approach methodologies (NAMs) and artificial intelligence to avoid animal testing methods; welcomes, in particular, the use of in vitro battery testing regarding neurodevelopment disorders in children;
Amendment 6 #
Draft opinion
Paragraph 4 b (new)
Paragraph 4 b (new)
4 b. Welcomes EFSA's efforts to increase the use of new approach methodologies (NAMs) in the agency's human health risk assessment to reduce and replace the need for animal-based verification studies, so that by 2027 the large majority of EFSA requests for additional data will be based on NAMs;